Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             177 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects Sackmann-Sala, Lucila
2009
69-70 6 p. 471-477
7 p.
artikel
2 A 3-day high-fat/low-carbohydrate diet does not alter exercise-induced growth hormone response in healthy males Sasaki, Hiroto
2015
69-70 6 p. 304-311
8 p.
artikel
3 Addition of IGF-I to storage-cooled boar semen and its effect on sperm quality Silva, D.M.
2011
69-70 6 p. 325-330
6 p.
artikel
4 After 6years of intraperitoneal insulin administration IGF-I concentrations in T1DM patients are at low-normal level van Dijk, Peter R.
2015
69-70 6 p. 316-319
4 p.
artikel
5 Aims & Scope/Editorial Board 2009
69-70 6 p. i-
1 p.
artikel
6 Aims & Scope/Editorial Board 2002
69-70 6 p. i-
1 p.
artikel
7 Aims & Scope/Editorial Board 2008
69-70 6 p. i-
1 p.
artikel
8 Aims & Scope/Editorial Board 2005
69-70 6 p. i-
1 p.
artikel
9 Aims & Scope/Editorial Board 2007
69-70 6 p. i-
1 p.
artikel
10 Aims & Scope/Editorial Board 2012
69-70 6 p. i-
1 p.
artikel
11 Analysis of the GH content within archived dried blood spots of newborn screening cards from children diagnosed with growth hormone deficiency after the neonatal period Binder, G.
2011
69-70 6 p. 314-317
4 p.
artikel
12 Analysis of the relationship of insulin-like growth factor-1 to the growth velocity and feeding of healthy infants Wang, Xinli
2013
69-70 6 p. 215-219
5 p.
artikel
13 22- and 20kDa-human growth hormones bind to different sites within certain cellular receptors Longhi, Silvia A.
2003
69-70 6 p. 353-360
8 p.
artikel
14 A novel and de novo splice-donor site mutation in intron 3 of the GH-1 gene in a patient with isolated growth hormone deficiency Katsumata, N
2001
69-70 6 p. 378-383
6 p.
artikel
15 A novel gross indel in the growth hormone releasing hormone receptor gene of Indian IGHD patients Kale, Shantanu
2014
69-70 6 p. 227-232
6 p.
artikel
16 A novel heterozygous T51I mutation of growth hormone receptor is not associated with short stature Sakurai, Tatsuya
2002
69-70 6 p. 411-417
7 p.
artikel
17 A novel mutation at the donor splice site of intron 3 of the GH-I gene in a patient with isolated growth hormone deficiency Hayashi, Yoshitaka
1999
69-70 6 p. 434-437
4 p.
artikel
18 A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation Li, Yangxin
2010
69-70 6 p. 391-398
8 p.
artikel
19 Are the insulin-like growth factors relevant to cancer? Yee, Douglas
2001
69-70 6 p. 339-345
7 p.
artikel
20 Association between dietary folate intake and serum insulin-like growth factor-1 levels in healthy old women Carraro, S.
2013
69-70 6 p. 267-271
5 p.
artikel
21 Association of circulating IGF-I and IGFBP-3 concentrations and exercise capacity in healthy volunteers: Results of the Study of Health in Pomerania Gläser, Sven
2010
69-70 6 p. 404-410
7 p.
artikel
22 Association of serum components of the GH-IGFs-IGFBPs system with GHR-exon 3 polymorphism in normal and idiopathic short stature children Ballerini, María Gabriela
2013
69-70 6 p. 229-236
8 p.
artikel
23 Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5years Ross, Judith L.
2015
69-70 6 p. 286-293
8 p.
artikel
24 Author Index 2000
69-70 6 p. ix-xiv
nvt p.
artikel
25 Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiation Elbornsson, Mariam
2013
69-70 6 p. 249-255
7 p.
artikel
26 Biochemical markers of bone turnover in tibia fracture patients randomly assigned to growth hormone (GH) or placebo injections Krusenstjerna-Hafstrøm, Thomas
2011
69-70 6 p. 331-335
5 p.
artikel
27 Bone metabolism in relation to alterations in systemic growth hormone Ueland, Thor
2004
69-70 6 p. 404-417
14 p.
artikel
28 Changes in serum insulin-like growth factor binding protein-2, -3, and -6 levels in patients with chronic renal failure following renal transplantation Fukuda, I.
1998
69-70 6 p. 481-486
6 p.
artikel
29 Characterization of an amino-terminal fragment of insulin-like growth factor binding protein-3 and its effects in MCF-7 breast cancer cells Salahifar, Houta
2000
69-70 6 p. 367-377
11 p.
artikel
30 Characterization of the enzymatic specificity of the IGF-dependent insulin-like growth factor binding protein-4 (IGFBP-4) protease Chelius, Dirk
2000
69-70 6 p. 360-366
7 p.
artikel
31 Characterization of the IGF axis in a rat liver-derived epithelial cell line Bramani, Silvia
1999
69-70 6 p. 425-433
9 p.
artikel
32 Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patients Janukonyté, J.
2013
69-70 6 p. 256-260
5 p.
artikel
33 Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis Hosback, Sharah
2007
69-70 6 p. 472-479
8 p.
artikel
34 Cissus quadrangularis augments IGF system components in human osteoblast like SaOS-2 cells Muthusami, Sridhar
2011
69-70 6 p. 343-348
6 p.
artikel
35 Clinical implications of the IGF-cancer connection Cohen, Pinchas
2001
69-70 6 p. 336-338
3 p.
artikel
36 Column chromatographic characterization of complex formation of pro-IGF-II isoforms with acid labile subunit and IGF-binding proteins associated with non-islet cell tumour induced hypoglycaemia van Veggel, K.M.
2014
69-70 6 p. 233-238
6 p.
artikel
37 Common polymorphisms in the GH/IGF-1 axis contribute to growth in extremely tall subjects Hendriks, A.E.J.
2011
69-70 6 p. 318-324
7 p.
artikel
38 Comparison of methods of analysis of body composition in hypophysectomized rats treated with rat growth hormone Johansen, Peter B.
2000
69-70 6 p. 342-348
7 p.
artikel
39 Continuous administration of growth hormone does not prevent the decrease of IGF-I gene expression in zinc-deprived rats despite normalization of liver GH binding Ninh, N.X.
1998
69-70 6 p. 465-472
8 p.
artikel
40 Contribution of circulating IGF-I to wound repair in GH-treated rats Dunaiski, V
2002
69-70 6 p. 381-387
7 p.
artikel
41 Cord blood triglycerides are associated with IGF-I levels and contribute to the identification of growth-restricted neonates Sifianou, Popi
2012
69-70 6 p. 219-223
5 p.
artikel
42 Corneal endothelial cell density and morphology in patients with acromegaly Hatipoglu, Esra
2014
69-70 6 p. 260-263
4 p.
artikel
43 Decreased IGF-1 levels potentiate association of inflammation with all-cause and cardiovascular mortality in prevalent hemodialysis patients Beberashvili, Ilia
2013
69-70 6 p. 209-214
6 p.
artikel
44 Depolarization induces insulin-like growth factor binding protein-2 expression in vivo via NMDA receptor stimulation Holmin, S
2001
69-70 6 p. 399-406
8 p.
artikel
45 Design and interpretation of studies of the risk of cancer and other long-term morbidity and mortality after growth hormone treatment Swerdlow, A.J.
2000
69-70 6 p. 318-323
6 p.
artikel
46 Determination of IGF-I, IGF-II, IGFBP-2, and IGFBP-3 levels in serum and plasma: comparisons using the Bland–Altman method Renehan, Andrew G
2003
69-70 6 p. 341-346
6 p.
artikel
47 Diet, body composition, and physical fitness influences on IGF-I bioactivity in women Philip Karl, J.
2009
69-70 6 p. 491-496
6 p.
artikel
48 Divergent regulation of proteasomes by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone Chrysis, Dionisios
2002
69-70 6 p. 434-441
8 p.
artikel
49 Does the GH–IGF axis play a role in cancer pathogenesis? Cohen, Pinchas
2000
69-70 6 p. 297-305
9 p.
artikel
50 Editorial Board 2013
69-70 6 p. i-
1 p.
artikel
51 Editorial Board 2010
69-70 6 p. i-
1 p.
artikel
52 Editorial board 2003
69-70 6 p. i-
1 p.
artikel
53 Editorial board 2004
69-70 6 p. i-
1 p.
artikel
54 Editorial Board 2014
69-70 6 p. i-
1 p.
artikel
55 Editorial Board 2015
69-70 6 p. i-
1 p.
artikel
56 Editorial Board 2011
69-70 6 p. i-
1 p.
artikel
57 Effects of active vs. passive recovery during Wingate-based training on the acute hormonal, metabolic and psychological response Wahl, Patrick
2013
69-70 6 p. 201-208
8 p.
artikel
58 Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients Laursen, Torben
1999
69-70 6 p. 451-457
7 p.
artikel
59 Effects of growth hormone overexpression vs. growth hormone receptor gene disruption on mouse hindlimb muscle fiber type composition Schuenke, Mark D.
2008
69-70 6 p. 479-486
8 p.
artikel
60 Effects of hypophysectomy and growth hormone administration on the mRNA levels of collagen I, III and insulin-like growth factor-I in rat skeletal muscle Wilson, V.J.
1998
69-70 6 p. 431-438
8 p.
artikel
61 Effects of isolated GH deficiency on adipose tissue, feeding and adipokines in mice Recinella, Lucia
2013
69-70 6 p. 237-242
6 p.
artikel
62 Effects of lowering circulating free fatty acid levels on protein metabolism in adult growth hormone deficient patients Nielsen, Steen
2002
69-70 6 p. 425-433
9 p.
artikel
63 Electronic publishing—lessons learned Sonsken, Peter
1998
69-70 6 p. 429-
1 p.
artikel
64 Elevated insulin, proinsulin and insulin-like growth factor-binding protein-1 in liver disease Hwang, David L
2003
69-70 6 p. 316-321
6 p.
artikel
65 Evaluation of growth hormone stimulation tests in cured acromegalic patients Conceição, Flavia Lucia
2003
69-70 6 p. 347-352
6 p.
artikel
66 Evaluation of IGF-2/ApaI polymorphism in pregnant women infected with human immunodeficiency virus type 1 taking antiretroviral drugs Marcolin, Alessandra C.
2009
69-70 6 p. 513-516
4 p.
artikel
67 Expression of insulin-like growth factor system constituents in differentiating rat osteoblastic cell populations Jia, Dan
2002
69-70 6 p. 399-410
12 p.
artikel
68 Frailty and the biochemical effects of recombinant human growth hormone in women after surgery for hip fracture Yeo, A.-L.
2003
69-70 6 p. 361-370
10 p.
artikel
69 Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia Holt, R.I.G.
1998
69-70 6 p. 447-454
8 p.
artikel
70 Genetic variation in the type 2 insulin-like growth factor receptor gene and disparity in childhood height Petry, Clive J.
2005
69-70 6 p. 363-368
6 p.
artikel
71 Genomic imprinting of insulin-like growth factor 2 (IGF-2) in chronic synovitis Möller, B.
2007
69-70 6 p. 500-505
6 p.
artikel
72 GH and the heart: potential therapeutic use Isgaard, Jörgen
2000
69-70 6 p. 295-296
2 p.
artikel
73 GH responses to two consecutive bouts of whole body vibration, maximal voluntary contractions or vibration alternated with maximal voluntary contractions administered at 2-h intervals in healthy adults Sartorio, A.
2010
69-70 6 p. 416-421
6 p.
artikel
74 GH secretion in acute exercise may result in post-exercise lipolysis Wee, Jamie
2005
69-70 6 p. 397-404
8 p.
artikel
75 Growth hormone action in puberty: Effects by gender Mauras, Nelly
2007
69-70 6 p. 463-471
9 p.
artikel
76 Growth hormone and the risk of atherosclerosis in growth hormone-deficient children Binay, Cigdem
2015
69-70 6 p. 294-297
4 p.
artikel
77 Growth hormone deficient patients after traumatic brain injury – Baseline characteristics and benefits after growth hormone replacement – An analysis of the German KIMS database Kreitschmann-Andermahr, I.
2008
69-70 6 p. 472-478
7 p.
artikel
78 Growth hormone (GH) replacement in GH-deficient adults: a crossover trial comparing the effect on metabolic control, well-being and compliance of three injections per week versus daily injections Johansson, Jan-Ove
2003
69-70 6 p. 306-315
10 p.
artikel
79 Growth hormone induced lipolysis during short- and long-term administration in adult Prader–Willi patients Höybye, Charlotte
2005
69-70 6 p. 411-415
5 p.
artikel
80 Growth hormone potentiates thyroid hormone effects on post-exercise phosphocreatine recovery in skeletal muscle Kaminsky, P.
2012
69-70 6 p. 240-244
5 p.
artikel
81 Growth hormone receptor antagonist improves insulin resistance in acromegaly Rose, D.Roderick
2002
69-70 6 p. 418-424
7 p.
artikel
82 Growth hormone receptor immunoreactivity is increased in the subventricular zone of juvenile rat brain after focal ischemia: A potential role for growth hormone in injury-induced neurogenesis Christophidis, Larissa Joy
2009
69-70 6 p. 497-506
10 p.
artikel
83 Growth hormone replacement normalizes impaired fibrinolysis: New insights into endothelial dysfunction in patients with hypopituitarism and growth hormone deficiency Miljic, D.
2013
69-70 6 p. 243-248
6 p.
artikel
84 Growth hormone replacement therapy in Costello syndrome Triantafyllou, Panagiota
2014
69-70 6 p. 271-275
5 p.
artikel
85 Heterozygous mutations of growth hormone receptor gene in children with idiopathic short stature Bonioli, Eugenio
2005
69-70 6 p. 405-410
6 p.
artikel
86 Human growth hormone measurement by means of a sensitive ELISA of whole blood spots on filter paper Langkamp, M.
2008
69-70 6 p. 526-532
7 p.
artikel
87 Hypopituitary patients prefer a touch-screen to paper quality of life questionnaire Goodhart, I.M.
2005
69-70 6 p. 384-387
4 p.
artikel
88 IGF binding protein-1 (IGFBP-1) is preferentially associated with the fetal-facing basal surface of the syncytiotrophoblast in the human placenta Fang, Junguo
1999
69-70 6 p. 438-444
7 p.
artikel
89 IGFBP-1 predicts all-cause mortality in elderly women independently of IGF-I Nolte, Agneta Aili
2015
69-70 6 p. 281-285
5 p.
artikel
90 IGFBP-1 protease activity and IGFBP-1 fragments in a patient with multiple myeloma Brandt, Katrin
2009
69-70 6 p. 507-512
6 p.
artikel
91 IGF(CA)19 and IGFBP-3-202A/C gene polymorphism in patients with acromegaly Akin, Fulya
2010
69-70 6 p. 399-403
5 p.
artikel
92 IGF-I and not IGF-II expression is regulated by glucocorticoids in human fetal epiphyseal chondrocytes Fernandez-Cancio, M.
2008
69-70 6 p. 497-505
9 p.
artikel
93 IGF-I at 9 and 36months of age — relations with body composition and diet at 3years — the SKOT cohort Ejlerskov, K.T.
2014
69-70 6 p. 239-244
6 p.
artikel
94 IGF-I improved bone mineral density and body composition of weaver mutant mice Yao, Weiguo
2008
69-70 6 p. 517-525
9 p.
artikel
95 IL-6-overexpression brings about growth impairment potentially through a GH receptor defect Lieskovska, Jaroslava
2002
69-70 6 p. 388-398
11 p.
artikel
96 Importance of circulating IGF-1 for normal cardiac morphology, function and post infarction remodeling Täng, M. Scharin
2012
69-70 6 p. 206-211
6 p.
artikel
97 Improved glycemic control due to sitagliptin is not related to cortisol or the surrogate marker IGFBP-1 for hepatic insulin sensitivity Arnetz, Lisa
2015
69-70 6 p. 298-303
6 p.
artikel
98 Increased 24h mean insulin-like growth factor binding protein-3 proteolytic activity in pubertal type 1 diabetic boys Zachrisson, I.
2000
69-70 6 p. 324-331
8 p.
artikel
99 Index to Vol. 12 2002
69-70 6 p. 443-452
10 p.
artikel
100 Index to Volume 13 2003
69-70 6 p. 371-380
10 p.
artikel
101 Index to volume 8, 1998 1998
69-70 6 p. i-xx
nvt p.
artikel
102 Index to volume 14 2004
69-70 6 p. 467-474
8 p.
artikel
103 Inhibition of human osteoblast marker gene expression by retinoids is mediated in part by insulin-like growth factor binding protein-6 Yan, Tao
2001
69-70 6 p. 368-377
10 p.
artikel
104 Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir Varewijck, A.J.
2010
69-70 6 p. 427-431
5 p.
artikel
105 Insulin–glucose infusion given before hemodialysis increases IGF-I in type 2 diabetes patients with chronic kidney disease Lindgren, Björn F.
2010
69-70 6 p. 422-426
5 p.
artikel
106 Insulin-like growth factor action and skeletal muscle growth, an in vivo perspective Rotwein, Peter
2003
69-70 6 p. 303-305
3 p.
artikel
107 Insulin-like growth factor-I downregulates embryonic myosin heavy chain (eMyHC) in myoblast nuclei Rodgers, Buel D.
2005
69-70 6 p. 377-383
7 p.
artikel
108 Insulin-like-growth-factor-I (IGF-I) antagonizes apoptosis induced by serum deficiency and doxorubicin in neuronal cell culture Gil-Ad, I.
1999
69-70 6 p. 458-464
7 p.
artikel
109 Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure Houang, Muriel
2000
69-70 6 p. 332-341
10 p.
artikel
110 Insulin-like growth factor I levels during growth hormone (GH) replacement in GH-deficient adults: a gender difference Soares, D.V.
2004
69-70 6 p. 436-441
6 p.
artikel
111 Insulin-like growth factor system gene expression in cervical scrapes from women with squamous intraepithelial lesions and cervical cancer Serrano, Martha-Lucía
2007
69-70 6 p. 492-499
8 p.
artikel
112 Interactions between oral contraceptive status and GSTM1 and GSTT1 deletions on insulin-like growth factor-1 (IGF-1) plasma levels in young healthy women Henningson, M.C.K.
2010
69-70 6 p. 432-437
6 p.
artikel
113 Interstitial fluid contains higher in vitro IGF bioactivity than serum: A study utilizing the suction blister technique Espelund, Ulrick
2012
69-70 6 p. 234-239
6 p.
artikel
114 Introducing a new Editorial Board member 2004
69-70 6 p. 403-
1 p.
artikel
115 Investigation of PAX3/7-FKHR fusion genes and IGF2 gene expression in rhabdomyosarcoma tumors de Souza, Robson Ramos
2012
69-70 6 p. 245-249
5 p.
artikel
116 Involvement of sensory nerves in the protective effect of growth hormone on acute pancreatitis Jaworek, Jolanta
2009
69-70 6 p. 517-522
6 p.
artikel
117 Isocaloric high-protein diet as well as branched-chain amino acids supplemented diet partially alleviates adverse consequences of maternal undernutrition on fetal growth Mogami, Haruta
2009
69-70 6 p. 478-485
8 p.
artikel
118 Lack of contribution of 11βHSD1 and glucocorticoid action to reduced muscle mass associated with reduced growth hormone action Itoh, Emina
2004
69-70 6 p. 462-466
5 p.
artikel
119 Lactate activates the somatotropic axis in rats Salgueiro, Rafael Barrera
2014
69-70 6 p. 268-270
3 p.
artikel
120 Large fat and skin necroses after deep subcutaneous injections of a slow-release somatostatin analogue in a woman with acromegaly Burman, Pia
2010
69-70 6 p. 438-440
3 p.
artikel
121 Lower levels of placental growth hormone in early pregnancy in women with type 1 diabetes and large for gestational age infants Ringholm, Lene
2015
69-70 6 p. 312-315
4 p.
artikel
122 Management of growth hormone deficiency in adults Nilsson, Anna G.
2007
69-70 6 p. 441-462
22 p.
artikel
123 Mass spectrometric characterization of a biotechnologically produced full-length mechano growth factor (MGF) relevant for doping controls Thevis, Mario
2014
69-70 6 p. 276-280
5 p.
artikel
124 Maternal nutrition affects the ability of treatment with IGF-I and IGF-II to increase growth of the placenta and fetus, in guinea pigs Sohlström, A
2001
69-70 6 p. 392-398
7 p.
artikel
125 Methylprednisolone does not inhibit the release of growth hormone after intravenous injection of a novel growth hormone secretagogue in rats Malmlöf, K.
1999
69-70 6 p. 445-450
6 p.
artikel
126 Mini-review: estrogen action in the uterus and insulin-like growth factor-I Moyano, Paula
2004
69-70 6 p. 431-435
5 p.
artikel
127 Motor and memory testing of long-lived pregnancy-associated plasma protein—A knock-out mice Mason, Emily J.
2014
69-70 6 p. 251-255
5 p.
artikel
128 Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults Mattsson, Anders
2008
69-70 6 p. 506-516
11 p.
artikel
129 Multi-hormonal regulation of IGFBP-6 expression in human neuroblastoma cells Chambery, Daniel
2000
69-70 6 p. 349-359
11 p.
artikel
130 Muscular dystrophy-related quantitative and chemical changes in adenohypophysis GH-cells in golden retrievers de Lima, A.R.
2007
69-70 6 p. 480-491
12 p.
artikel
131 Nanotopology potentiates growth hormone signalling and osteogenesis of mesenchymal stem cells Wang, Jessie R.
2014
69-70 6 p. 245-250
6 p.
artikel
132 PAPP-A2 expression by osteoblasts is required for normal postnatal growth in mice Amiri, Neilab
2015
69-70 6 p. 274-280
7 p.
artikel
133 Peptides associated with hyperphagia in adults with Prader–Willi syndrome before and during GH treatment Höybye, Charlotte
2003
69-70 6 p. 322-327
6 p.
artikel
134 Phosphoisoforms of insulin-like growth factor binding protein-1 in appropriate-for-gestational-age and small-for-gestational-age fetuses Iwashita, M.
1998
69-70 6 p. 487-493
7 p.
artikel
135 Pituitary hormone deficiencies due to transcription factor gene alterations Reynaud, R.
2004
69-70 6 p. 442-448
7 p.
artikel
136 Plasma insulin-like growth factor I as predictor of progression and all cause mortality in chronic heart failure Andreassen, Mikkel
2009
69-70 6 p. 486-490
5 p.
artikel
137 Plasma levels of active and total ghrelin in renal failure: A relationship with GH/IGF-I axis Jarkovská, Z.
2005
69-70 6 p. 369-376
8 p.
artikel
138 Population pharmacokinetic model for human growth hormone in adult patients in chronic dialysis compared with healthy subjects Klitgaard, Thomas
2009
69-70 6 p. 463-470
8 p.
artikel
139 Pregnancy-associated plasma protein-A expression in human breast cancer Mansfield, Aaron S.
2014
69-70 6 p. 264-267
4 p.
artikel
140 Protein metabolism and the use of growth hormone and insulin-like growth factor-I in the critically ill patient Carroll, Paul V.
1999
69-70 6 p. 400-413
14 p.
artikel
141 QTLs influencing IGF-1 levels in a LOU/CxFischer 344F2 rat population. Tracks towards the metabolic theory of Ageing Marissal-Arvy, Nathalie
2013
69-70 6 p. 220-228
9 p.
artikel
142 Recombinant human insulin-like growth factor-binding protein 3 inhibits tumor growth and targets the Akt pathway in lung and colon cancer models Alami, Nezha
2008
69-70 6 p. 487-496
10 p.
artikel
143 Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease Katsanos, Konstantinos H
2001
69-70 6 p. 364-367
4 p.
artikel
144 Reflections from a 40 year journey with growth hormone and IGF-I Sönksen, Peter
2001
69-70 6 p. 329-335
7 p.
artikel
145 Regulation of IGFBP3 gene expression in short children born small for gestational age Faienza, M.F.
2011
69-70 6 p. 349-355
7 p.
artikel
146 Regulation of the insulin-like growth factor axis by increasing cell number in intestinal epithelial (IEC-6) cells Corkins, Mark R.
1999
69-70 6 p. 414-424
11 p.
artikel
147 Reproducibility of the growth hormone response to sprint exercise Stokes, Keith A.
2003
69-70 6 p. 336-340
5 p.
artikel
148 Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts Conover, Cheryl A.
2003
69-70 6 p. 328-335
8 p.
artikel
149 Role of insulin-like growth factor-I (IGF-I) receptor, IGF-I, and IGF binding protein-2 in human colorectal cancers Mishra, L.
1998
69-70 6 p. 473-479
7 p.
artikel
150 Role of the GH/IGF-1 axis in lifespan and healthspan: Lessons from animal models Berryman, Darlene E.
2008
69-70 6 p. 455-471
17 p.
artikel
151 Roles of insulin-like growth factor-I (IGF-I) and IGF-I binding protein-2 (IGFBP2) and -5 (IGFBP5) in developing chick limbs McQueeney, Kelly
2001
69-70 6 p. 346-363
18 p.
artikel
152 Safety issues in children and adolescents during growth hormone therapy—a review Clayton, Peter E.
2000
69-70 6 p. 306-317
12 p.
artikel
153 Serum adiponectin levels in adult growth hormone deficiency and acromegaly Fukuda, Izumi
2004
69-70 6 p. 449-454
6 p.
artikel
154 Serum IGF-1 is higher in patients with idiopathic normal pressure hydrocephalus than in the population Yang, Y.
2015
69-70 6 p. 269-273
5 p.
artikel
155 Serum levels of insulin-like growth factor-I in relation to organochlorine pesticides exposure Boada, Luis D.
2007
69-70 6 p. 506-511
6 p.
artikel
156 Sexual dimorphism in growth and insulin-like growth factor-I in children with type 1 diabetes mellitus Bizzarri, Carla
2014
69-70 6 p. 256-259
4 p.
artikel
157 Spontaneous growth hormone secretion and IGF1:IGFBP3 molar ratios in children born small for gestational age (SGA) Völkl, Thomas M.K.
2004
69-70 6 p. 455-461
7 p.
artikel
158 Subject Index 2000
69-70 6 p. xv-xx
nvt p.
artikel
159 The benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational age Kappelgaard, Anne-Marie
2011
69-70 6 p. 305-313
9 p.
artikel
160 The changes of IGF binding proteins after rhGH administration to patients totally dependent on parenteral nutrition Justová, V
2001
69-70 6 p. 407-415
9 p.
artikel
161 The complex relationship between obesity and the somatropic axis: The long and winding road Savastano, Silvia
2014
69-70 6 p. 221-226
6 p.
artikel
162 The effects of ovine placental lactogen and bovine growth hormone on hepatic and mammary gene expression in lactating sheep Bassett, N.S.
1998
69-70 6 p. 439-446
8 p.
artikel
163 The GHRH+arginine stimulated pituitary GH secretion in children and adults with Prader–Willi syndrome shows age- and BMI-dependent and genotype-related differences Marostica, E.
2013
69-70 6 p. 261-266
6 p.
artikel
164 The insulin like growth factor system in cirrhosis. Relation to changes in body composition following adrenoreceptor blockade Bonefeld, Karen
2012
69-70 6 p. 212-218
7 p.
artikel
165 The p53-family members p63 and p73 inhibit insulin-like growth factor-I receptor gene expression in colon cancer cells Nahor, Irit
2005
69-70 6 p. 388-396
9 p.
artikel
166 The physiological and pathophysiological roles of the GH/IGF-axis in the kidney: Lessons from experimental rodent models Cingel-Ristić, Vesna
2004
69-70 6 p. 418-430
13 p.
artikel
167 The production and regulation of IGF and IGFBPs in human adipose tissue cultures Gude, Mette Faurholdt
2012
69-70 6 p. 200-205
6 p.
artikel
168 The relation between insulin-like growth factor I levels and cognition in healthy elderly: A meta-analysis Arwert, L.I.
2005
69-70 6 p. 416-422
7 p.
artikel
169 The role of insulin-like growth factor-1 and growth hormone in the mortality of patients with acromegaly after trans-sphenoidal surgery Wu, Tzu-En
2010
69-70 6 p. 411-415
5 p.
artikel
170 The role of the insulin-like growth factor-I receptor in malignancy: An update Seccareccia, Erica
2012
69-70 6 p. 193-199
7 p.
artikel
171 Thrity-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients Baxter, R.C.
1998
69-70 6 p. 455-463
9 p.
artikel
172 Total and free insulin-like growth factor I, insulin-like growth factor binding protein 3 and acid-labile subunit reflect clinical activity in acromegaly Sneppen, S.B
2001
69-70 6 p. 384-391
8 p.
artikel
173 Transcriptional response of peripheral blood mononuclear cells to recombinant human growth hormone in a routine four-days IGF-I generation test Welzel, Maik
2011
69-70 6 p. 336-342
7 p.
artikel
174 Upregulation of the angiotensin-converting enzyme 2/angiotensin-(1–7)/Mas receptor axis in the heart and the kidney of growth hormone receptor knock-out mice Giani, Jorge F.
2012
69-70 6 p. 224-233
10 p.
artikel
175 Volume Contents 2000
69-70 6 p. i-viii
nvt p.
artikel
176 Volume Index 2005 2005
69-70 6 p. 423-433
11 p.
artikel
177 Whither growth hormone in the catabolic state of critical illness? Berghe, Greet Van den
1999
69-70 6 p. 397-399
3 p.
artikel
                             177 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland